期刊文献+

原发性高血压患者血压变异性与血浆神经肽Y及神经降压素水平关系研究 被引量:5

Ralationship between blood pressure variability and the plasma neuropeptide Y and neurotensin in patients with essential hypertension
下载PDF
导出
摘要 目的探讨原发性高血压患者血压变异性(BPV)与血浆神经肽Y(NPY)及神经降压素(NT)水平关系。方法选择2014年12月至2016年6月重钢总医院收治的原发性高血压患者60例,根据血压水平分为原发性高血压1级(高血压1组,22例)、原发性高血压2级(高血压2组,20例)及原发性高血压3级(高血压3组,18例),同时选择健康体检者20例作为对照组。各组均进行24 h动态血压监测,同时检测血浆NPY及NT水平。结果高血压患者(高血压1、2、3组)的24小时收缩压变异(24hSBPV)、昼间收缩压变异(DSBPV)、夜间收缩压变异(NSBPV)、24小时舒张压变异(24hDBPV)、昼间舒张压变异(DDBPV)、夜间舒张压变异(NDBPV)均高于对照组,高血压3组以上指标均显著高于高血压1、2组,高血压2组以上指标显著高于高血压1组,差异均有统计学意义(P<0.05);高血压患者(高血压1、2、3组)的血浆NPY水平均高于对照组,高血压3组均显著高于高血压1、2组,高血压2组显著高于1组,差异均有统计学意义(P<0.05);高血压患者(高血压1、2、3组)的血浆NT水平均低于对照组,高血压3组均显著低于高血压1、2组,高血压2组显著低于高血压1组,差异均有统计学意义(P<0.05)。Pearson相关性分析显示,24hSBPV、DSBPV、NSBPV、24hDBPV、DDBPV、NDBPV均与NPY呈正相关(P<0.05),与NT呈负相关(P<0.05)。结论血压变异性升高与NPY存呈正相关,与NT呈负相关,NPY及NT可能参与了血压变异发病机制。 Objective To investigate the rationship between blood pressure variability and the plasma neuropeptide Y(NPY)and neurotensin(NT)in patients with essential60 patients with essential hypertension admitted to the General Hospitsal of Chongqing from December 2014 to June 2017 were divided into three groups according to the level of blood pressure:essential hypertension grade 1(group 1,n=22),essential hypertension grade 2(group 2,n=20)and essential hypertension grade 3(group 3,n=18),meanwhile,20 healthy subjects were selected control group.24 hours ambulatory blood pressure monitoring and detection of plasma NPY and NT were performed in each group.hour systolic blood pressure variability(24hSBPV),daytime systolic blood pressure variability(DSBPV),night systolic blood pressure variation(NSBPV),24 hour diastolic blood pressure variability(24hDBPV),daytime diastolic blood pressure variability(DDBPV),night diastolic blood pressure variation(NDBPV)of patients with hypertension(including group 1,group2,group3)were significantly higher than those of control group,the above indicators of group3 were significantly higher than those of group2 and group 1,the above indicators of group2 were significantly higher than those of group 1,the differences were statistically significant(P0.05).The level of plasma NPY of patients with hypertension(including group 1,group2,group3)were significantly higher than those of control group,group3 was significantly higher than group2 and group 1,group2 was significantly higher than group 1,the differences were statistically significan(tP0.05);The level of plasma NT of patients with hypertension(including group 1,group2,group3)were significantly lower than those of control group,group3 was significantly lower than group2 and group 1,group2 was significantly lower than group 1,the differences were statistically significan(tP0.05).Pearson correlation analysis showed that 24hSBPV,DSBPV,NSBPV,24hDBPV,DDBPV,NDBPV and NPY had a positive correlation(P0.05),and NT had a negativeThere is a positive correlation between blood pressure variability and NPY,and negatively correlated with NT,NPY and NT may be involved in the pathogenesis of blood pressure variability.
作者 何杰 普春云 戴亨华 HE Jie,PU Chunyun,DAI Henghua(Department of Cardiology,General Hospital of Chonggang,Department of Cardiology,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
出处 《现代医药卫生》 2018年第20期3132-3134,共3页 Journal of Modern Medicine & Health
基金 重庆市卫生和计划生育委员会医学科研计划项目(2013-2-193)
关键词 高血压 神经肽Y 变异性 神经降压素 Hypertension NeuropeptideY Variability Neurotensin
  • 相关文献

参考文献5

二级参考文献39

  • 1江时森,赵技文.高血压病患者不同时期调节肽的变化及其临床意义[J].中华心血管病杂志,1993,21(3):144-146. 被引量:6
  • 2张文华,夏稻子,张宇虹,林萍,高林,礼广森,由悦.定量组织速度成像对高血压患者左室心肌功能的评价[J].高血压杂志,2005,13(4):221-225. 被引量:17
  • 3朱志林,王静,刘红,冷柏华,梅苑.老年高血压患者动态血压负荷值与靶器官损害相关性分析[J].临床心血管病杂志,2005,21(5):311-312. 被引量:40
  • 4张远强,国外医学心血管疾病分册,1990年,17卷,222页
  • 5Pedrazzini T,Pralong F,Grouzmann E. Neuropeptide Y: the universal soldier. Cell Mol Life Sci, 2003,60:350-377.
  • 6Michel MC,Rascher W. Neuropeptide Y: a possible role in hypertension. Hypertension, 1995,13:385-395.
  • 7Halawa B, Salomon P. Concentration of neuropeptide Y in serum of patients with primary hypertension. Pol Arch Mewn, 1996,95:420-426.
  • 8Zoccali C, Mallamaci F, Tripepi G, et al. Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease. J Hypertens, 2003,21:1263-1264.
  • 9Chen SH, Cheung RT. Peripheral and central administration of neuropeptide Y in a rat middle cerebral artery occlusion stroke model reduces cerebral blood flow and increases infarct volume. Brain Res, 2002,927:138-143.
  • 10Chen M, Li X, Dong Q, et al. Neuropeptide Y induces cardiomyocyte hypertrophy via calcineurin signaling in rats. Regul Pept, 2005,125:9-15.

共引文献98

同被引文献61

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部